ClinicalTrials.Veeva

Menu

Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population

R

Rudolf Foundation Clinic

Status

Unknown

Conditions

Age-Related Macular Degeneration

Treatments

Procedure: drawing blood

Study type

Interventional

Funder types

Other

Identifiers

NCT00533754
EK 06-076-VK

Details and patient eligibility

About

The aim of the study is to show a higher expression of the Y402H polymorphism in the complement factor H in patients with AMD compared to healthy individuals.

Additionaly a correlation between a subsided infection with chlamydia and patients with AMD and a factor H polymorphism will be investigated. An interrelationship with the VEGF-plasma level shall give more hints into the pathomechanism of AMD.

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • man and women over 18 years old
  • Filled out informed consentBereitschaft zur Teilnahme
  • Diagnosis of non-exudative/ exudative age related macular dgeneneration

Exclusion criteria

  • inherited retinal diseases
  • other aquired retinal/ macular
  • missing informed consent

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems